Regulation of the p73 protein stability and degradation Journal Article


Authors: Oberst, A.; Rossi, M.; Salomoni, P.; Pandolfi, P. P.; Oren, M.; Melino, G.; Bernassola, F.
Article Title: Regulation of the p73 protein stability and degradation
Abstract: p73, a homologue to the tumor suppressor gene p53, is involved in tumorigenesis, though its specific role remains unclear. The gene has two distinct promoters which allow the formation of two protein isoforms with opposite effects: full-length transactivating (TA) p73 shows pro-apoptotic effects, while the shorter ΔNp73, which lacks the N-terminal transactivating domain, has an evident anti-apoptotic function. Unlike p53, the p73 gene is rarely mutated in human cancers. However, alterations in the relative levels of TA and ΔNp73 have been shown to correlate with prognosis in several human cancers, suggesting that the fine regulation of these two isoforms is of pivotal importance in controlling proliferation and cell death. Much effort is currently focused on the elucidation of the mechanisms that differentially control TA and ΔNp73 activity and protein stability, a process complicated by the finding that both proteins are regulated by a similar suite of complex post-translational modifications that include ubiquitination, sequential phosphorylation, prolyl-isomerization, recruitment into the PML-nuclear body (PML-NB), and acetylation. Here we shall consider the main regulatory partners of p73, with particular attention to the recently discovered Itch- and Nedd8-mediated degradation pathways, along with the emerging roles of PML, p38 MAP kinase, Pin1, and p300 in p73 transcriptional activation, and possible mechanisms for the differential regulation of the TAp73 and ΔNp73 isoforms. © 2005 Elsevier Inc. All rights reserved.
Keywords: mitogen activated protein kinase; protein phosphorylation; gene mutation; dna-binding proteins; proto-oncogene proteins; review; ubiquitin; protein domain; protein function; cell proliferation; cell death; dna damage; cell cycle; apoptosis; gene expression; mitogen activated protein kinase p38; protein degradation; protein stability; nuclear proteins; ubiquitination; protein processing, post-translational; tumor suppressor proteins; transactivation; genes, tumor suppressor; nitrogen; p53; proto-oncogene proteins c-mdm2; acetylation; isomerization; promyelocytic leukemia protein; enzyme stability; protein p300; protein p73; nedd8; cell nucleus inclusion body; p73; itch; nedd8 protein
Journal Title: Biochemical and Biophysical Research Communications
Volume: 331
Issue: 3
ISSN: 0006-291X
Publisher: Elsevier Science, Inc.  
Date Published: 2005-06-10
Start Page: 707
End Page: 712
Language: English
DOI: 10.1016/j.bbrc.2005.03.158
PUBMED: 15865926
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 38" - "Export Date: 24 October 2012" - "CODEN: BBRCA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors